<?xml version="1.0" encoding="UTF-8"?>
<p>The Hospital-based Influenza Morbidity and Mortality (HIMM) surveillance system has been operated since 2011 as a research project of the Transgovernmental Enterprise for Pandemic Influenza in Korea [
 <xref rid="B25" ref-type="bibr">25</xref>]. The HIMM system is a kind of SARI surveillance system and has ten participating university hospitals. Respiratory specimens are collected at the sites for patients who visited the ER with ILI or hospitalized patients diagnosed with influenza. Medical histories are also collected, including influenza vaccination history, underlying medical condition, travel history, and the progress of influenza. Influenza-related statistics and collected data are reported on a daily and weekly basis. The HIMM data have been used to analyze the clinical course of severe influenza [
 <xref rid="B26" ref-type="bibr">26</xref>
 <xref rid="B27" ref-type="bibr">27</xref>], influenza disease burden [
 <xref rid="B28" ref-type="bibr">28</xref>], characteristics of influenza viruses that caused severe clinical course [
 <xref rid="B29" ref-type="bibr">29</xref>], influenza vaccine effectiveness, and so on. In addition to surveillance for severe influenza, there is surveillance for avian influenza viruses that can cause human infection such as A/H7N9 and A/H5N1 [
 <xref rid="B30" ref-type="bibr">30</xref>]. Currently, the HIMM surveillance system continues to be operated at nine hospitals.
</p>
